Adaptilens Featured in C&EN: Celebrating Founder-Led Biotech Innovation
Adaptilens is proud to be featured in C&EN’s insightful article by Rowan Walrath, highlighting the impact of founder-led biotech companies. We’re honored by the recognition of our Founder and CEO, Dr. Liane Clamen, and grateful for the spotlight on champions of the founder-led movement like Chris Garabedian, Gianna Hoffman-Luca, and the teams at Xontogeny, Perceptive […]
Adaptilens Announces $17.5M in Series A Financing
We are thrilled to announce that Adaptilens has secured $17.5 million in Series A financing, led by Xontogeny and Perceptive Xontogeny Venture Fund, with participation from Pillar VC and Accanto Partners. This significant investment will accelerate the development of our innovative accommodating intraocular lenses, bringing us closer to restoring natural focusing ability for patients worldwide.
Dr. Clamen featured in the When Science Speaks podcast
In the “When Science Speaks” podcast episode titled “Ophthalmology and Entrepreneurship with Liane Clamen, M.D.,” Dr. Clamen discusses her journey from practicing ophthalmology to founding Adaptilens, a company developing innovative intraocular lenses aimed at restoring the eye’s natural focusing ability. She shares insights into the challenges of transitioning from clinical practice to entrepreneurship, the importance […]
Dr. Clamen featured in the Amazing Execs episode 102 “Developing a Breakthrough New Ophthalmic Medical Device”
In Episode #102 of the Amazing Execs Show, Dr. Liane Clamen, CEO and founder of Adaptilens, discusses her journey in developing an accommodating intraocular lens designed to restore the eye’s natural focusing ability for cataract patients. She shares insights into the challenges of medical device startups, the importance of assembling a skilled and passionate team, […]
Adaptilens won a $75,000 Grand Prize award at the Harvard Innovation Lab’s President’s Innovation Challenge
Adaptilens was awarded $75,000 in the 2022 President’s Innovation Challenge for developing an intraocular lens that restores the eye’s ability to focus, offering a revolutionary approach to vision correction. Read the article
Adaptilens chosen to participate in Harvard’s highly selective Launch Lab X GEO accelerator
Adaptilens was honored to participate in the prestigious 2021 Launch Lab X GEO program at Harvard Innovation Labs. This six-month virtual accelerator provided unparalleled access to world-class experts, founder talks, leadership circles, and pitch sessions, culminating in participation in the President’s Innovation Challenge. The program supported Adaptilens’ mission to develop groundbreaking intraocular lenses that restore […]
Dr. Clamen receives the 2021 Massachusetts Next Generation award
In June 2021, the Massachusetts Life Sciences Center (MLSC) announced the 2021 awardees of the Massachusetts Next Generation Initiative (MassNextGen), a program supporting women entrepreneurs in early-stage life sciences companies. Among the five selected companies, Adaptilens, led by Founder and CEO Dr. Liane Clamen, received a grant of $87,500 and access to a network of […]
Polymeric Materials for Eye Surface and Intraocular Applications
The article “Polymeric Materials for Eye Surface and Intraocular Applications,” published in Biomacromolecules in February 2021, provides a comprehensive review of the development and application of polymeric materials in ophthalmology. Read the article
Announcing $1.6 million in seed funding led by Pillar VC additional participation from Accanto Partners
We are thrilled to announce that Adaptilens has secured $1.6 million in seed funding, led by Pillar VC with additional support from Accanto Partners. This funding marks an exciting step forward in our mission to revolutionize vision correction with our innovative accommodating intraocular lenses, restoring the eye’s natural ability to focus.
Adaptilens selected as a finalist for the 2020 MassChallenge Boston program
Adaptilens was honored to be selected as part of the 2020 MassChallenge Boston cohort, joining 100 innovative early-stage startups chosen from over 1,100 applicants worldwide. As a healthcare and life sciences venture, Adaptilens benefited from the program’s virtual format, gaining access to mentorship, a global network of experts, and corporate partnerships to advance its mission […]
